Literature DB >> 3294104

crl mutants of Saccharomyces cerevisiae resemble both mutants affecting general control of amino acid biosynthesis and omnipotent translational suppressor mutants.

J H McCusker1, J E Haber.   

Abstract

Cyocloheximide resistant lethal (crl) mutants of Saccharomyces cerevisiae, defining 22 unlinked complementation groups, are unable to grow at 37 degrees. They are also highly pleiotropic at their permissive temperature of 25 degrees. The mutants are all unable to arrest at the G1 stage of the cell cycle when grown to stationary phase or when starved for a single amino acid, though they do arrest at G1 when deprived of all nitrogen. The crl mutants are also hypersensitive to various amino acid analogs and to 3-aminotriazole. These mutants also "tighten" leaky auxotrophic mutations that permit wild-type cells to grow in the absence of the appropriate amino acid. All of these phenotypes are also exhibited by gcn mutants affecting general control of amino acid biosynthesis. In addition, the crl mutants are all hypersensitive to hygromycin B, an aminoglycoside antibiotic that stimulates translational misreading. The crl mutations also suppress one nonsense mutation which is phenotypically suppressed by hygromycin B. Many crl mutants are also osmotically sensitive. These are phenotypes which the crl mutations have in common with previously isolated omnipotent suppressors. We suggest that the the crl mutations all affect the fidelity of protein translation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294104      PMCID: PMC1203414     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  37 in total

1.  Selection of lys2 Mutants of the Yeast SACCHAROMYCES CEREVISIAE by the Utilization of alpha-AMINOADIPATE.

Authors:  B B Chattoo; F Sherman; D A Azubalis; T A Fjellstedt; D Mehnert; M Ogur
Journal:  Genetics       Date:  1979-09       Impact factor: 4.562

2.  Positive regulatory interactions of the HIS4 gene of Saccharomyces cerevisiae.

Authors:  G Lucchini; A G Hinnebusch; C Chen; G R Fink
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

3.  The effect of amino acid starvation on a major, acid soluble compound on Saccharomyces cerevisiae.

Authors:  E W Lusby; C S McLaughlin
Journal:  Mol Gen Genet       Date:  1980

4.  Characterization of Saccharomyces cerevisiae mutants supersensitive to aminoglycoside antibiotics.

Authors:  J F Ernst; R K Chan
Journal:  J Bacteriol       Date:  1985-07       Impact factor: 3.490

5.  New positive and negative regulators for general control of amino acid biosynthesis in Saccharomyces cerevisiae.

Authors:  M L Greenberg; P L Myers; R C Skvirsky; H Greer
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

6.  The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways.

Authors:  M Whiteway; J W Szostak
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

7.  Regulation of tryptophan biosynthesis in Saccharomyces cerevisiae: mode of action of 5-methyl-tryptophan and 5-methyl-tryptophan-sensitive mutants.

Authors:  A Schürch; J Miozzari; R Hütter
Journal:  J Bacteriol       Date:  1974-03       Impact factor: 3.490

8.  Isolation of the SUP45 omnipotent suppressor gene of Saccharomyces cerevisiae and characterization of its gene product.

Authors:  H J Himmelfarb; E Maicas; J D Friesen
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

9.  Positive regulation in the general amino acid control of Saccharomyces cerevisiae.

Authors:  A G Hinnebusch; G R Fink
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  Reserve carbohydrate metabolism in Saccharomyces cerevisiae: responses to nutrient limitation.

Authors:  S H Lillie; J R Pringle
Journal:  J Bacteriol       Date:  1980-09       Impact factor: 3.490

View more
  14 in total

1.  Gene conversion and crossing over along the 405-kb left arm of Saccharomyces cerevisiae chromosome VII.

Authors:  Anna Malkova; Johanna Swanson; Miriam German; John H McCusker; Elizabeth A Housworth; Franklin W Stahl; James E Haber
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

2.  Isolation and characterization of omnipotent suppressors in the yeast Saccharomyces cerevisiae.

Authors:  L P Wakem; F Sherman
Journal:  Genetics       Date:  1990-03       Impact factor: 4.562

3.  Homoserine toxicity in Saccharomyces cerevisiae and Candida albicans homoserine kinase (thr1Delta) mutants.

Authors:  Joanne M Kingsbury; John H McCusker
Journal:  Eukaryot Cell       Date:  2010-03-19

4.  Mutations in Saccharomyces cerevisiae which confer resistance to several amino acid analogs.

Authors:  J H McCusker; J E Haber
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

Review 5.  Modulation of efficiency of translation termination in Saccharomyces cerevisiae.

Authors:  Anton A Nizhnikov; Kirill S Antonets; Sergey G Inge-Vechtomov; Irina L Derkatch
Journal:  Prion       Date:  2014-11-01       Impact factor: 3.931

6.  Arabidopsis sensitivity to protein synthesis inhibitors depends on 26S proteasome activity.

Authors:  Jasmina Kurepa; Consolée Karangwa; Liliana Sfichi Duke; Jan A Smalle
Journal:  Plant Cell Rep       Date:  2010-01-20       Impact factor: 4.570

Review 7.  Polypeptide chain termination in Saccharomyces cerevisiae.

Authors:  I Stansfield; M F Tuite
Journal:  Curr Genet       Date:  1994-05       Impact factor: 3.886

Review 8.  Stationary phase in the yeast Saccharomyces cerevisiae.

Authors:  M Werner-Washburne; E Braun; G C Johnston; R A Singer
Journal:  Microbiol Rev       Date:  1993-06

9.  Cycloheximide-resistant temperature-sensitive lethal mutations of Saccharomyces cerevisiae.

Authors:  J H McCusker; J E Haber
Journal:  Genetics       Date:  1988-06       Impact factor: 4.562

10.  Nonrecombinant meiosis I nondisjunction in Saccharomyces cerevisiae induced by tRNA ochre suppressors.

Authors:  E J Louis; J E Haber
Journal:  Genetics       Date:  1989-09       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.